Abstract

Inflammatory bowel disease (IBD) is a heterogeneous disease with patients experiencing varying disease courses and response to therapy. Developing precision medicine approaches is of great interest and importance to improve care for IBD patients. Recent advances have the potential to change the way clinicians stratify patients and then select the most appropriate treatment based on an individualized assessment of risk of complications and drug response. In this chapter, we provide concluding remarks on the current evidence and potential for genomics in IBD care and future directions to bring precision medicine approaches to the clinic.

Original languageEnglish
Title of host publicationMolecular Genetics of Inflammatory Bowel Disease
PublisherSpringer
Pages381-389
Number of pages9
ISBN (Electronic)9783030287030
ISBN (Print)9783030287023
DOIs
StatePublished - 19 Dec 2019

Fingerprint

Dive into the research topics of 'Toward personalized therapy in inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this